[en] INTRODUCTION: Due to a rise in HCV induced liver cirrhosis, hepatocellular carcinoma becomes more prevalent in Western European countries. The HepCar registry is an initiative in which patients with hepatocellular carcinoma, their treatment and follow up are registered. MATERIALS AND METHODS: Belgian physicians were asked to report all new cases of hepatocellular carcinoma which were seen between January 2003 and December 2003. Reporting was done on a voluntary basis. Data reported were: demographic figures, the nature of the underlying liver disease, presentation characteristics of the tumour, laboratory findings and choice of therapy. Every six months, a reminder was sent to determine survival. RESULTS: 131 patients (94 male/37 female) were reported. Mean age was 63 years +/- 13. Underlying liver disease was HCV (n = 54, 41%), HBV (n = 22, 17%), alcoholic liver disease (n = 39, 30%) and miscellaneous (n =16, 12%). Diagnosis of hepatocellular carcinoma was made by surveillance in 47 (36%) patients. After logistic regression, survival was 5 times better for patients inside the Milan criteria (one lesion less than 5 cm in diameter or less than 3 nodules each less than 3 cm in the absence of vascular invasion and metastasis). DISCUSSION: Tumours inside the Milan criteria have a better survival. The majority of the patients have an underlying cirrhosis as background for the development of a HCC.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Van Vlierberghe, H.
Colle, I.
Henrion, J.
Michielsen, P.
Delwaide, Jean ; Centre Hospitalier Universitaire de Liège - CHU > Gastro-Entérologie-Hépatologie
Reynaert, H.
Borbath, I.
Martinet, J. P.
Sprengers, D.
Brenard, R.
Language :
English
Title :
The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC?
LONDON T., MEGLYNN K. Liver cancer. In: D. SCHOTTENFELD and J. FRAUMENI. cancer epidemiology and prevention, Oxford University Press, New-York, 1996%.
MEGLYNN K., TSAO L., HSING A., DEVESA S., FRAUMENI J. International trends and patterns of primary liver cancer. Int J Cancer, 2001, 90: 290-296.
EL-SERAG H., MASON A. Rising incidence of hepatocellular carcinoma in the United States. N Engl. J Med, 1999, 340: 745-750.
EL-SERAG H., MASON A. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med, 2000, 180: 3227-3230.
VAN VLIERBERGHE H., BORBATH I., DELWAIDE J., HENRION J., MICHIELSEN P., VERSLYPE Ch. (BASL HCC working group) and the BASL steering committee. BASL guidelines for the surveillance. diagnosis and treatment of hepatocellular carcinoma. Acta gastroenterol. belg., 2004, 67, 14-25.
COLOMBO M. Screening for cancer in viral hepatitis. Clin Liver Dis, 2001, 5: 109-121.
NGUYEN M., KEEFFE E. Screening for hepatocellular carcinoma. J Clin Gastroenterol, 2002, 35 (Suppl. 2): S86-91.
HENRION J., LIBON E., DE MAEGHT S., DELTENRE P., SCHAPIRA M., GHILAIN J.-M., MAISIN J.-M., HELLER F. Dépistage du carcinome hépatocellulaire dans une cohorte de malades porteurs d'une cirrhose d'origine principalement alcoolique. Gastroenterol Clin Biol, 2003, 27: 534-539.
ZOLI M., MAGALOTTI D., GUELLI C., MARCHESINI G., PISI E. Efficiency of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996, 78: 977-985.
COLOMBO M., DE FRANCHIS R., DEL NINNO E., SANGIOVANNI A., DE FAZIO C., TOMMASINI M., DONATO F., PIVA A., DI CARLO V., DIOGUARDIN N. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med, 1991, 325: 6.
PATERON D., GANNE N., TRINCHET J.-C. AUROUSSEAU M.-H., MAL F., MEICLER C., CODERC E., REBOULLET P., BEAUGRAND M. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol, 1994, 20: 65-71.
J. HENRION. Surveillance for hepatocellular carcinoma... A hotly debated issue. Acta gastroenterol. belg., 2004, 67, 255-264.
COTTONE M., VIRDONE R., FUSCO G., ORLANDO A., TURRI M. CALTAGIRONE H., MARINGHINI A., SCIARRINO E., DEMMA I., NICOLI N., TINE F., SAMMARCO S., PAGLIARO L. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment. Gastroenterology, 1989, 96: 1566-1571.
FAIVRE J., FORMAN D., ESTEVE J., OBRADOVIC M., SANT M. and the EUROCARE working group. - Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer, 1998, 34: 2184-2190.
EL-SERAG H., MASON A., KEY C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology, 2001, 33: 62-65.
BRUIX J., SHERMAN M., LLOVET J. M., BEAUGRAND M., LENCIONI R., BURROUGHS A. K., CHRISTENSEN E., PAGLIARO L., COLOMBO M., RODES J. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol, 2001, 35: 421-30.
MAZZAFERRO V., REGALIA E., DOCI R., ANDREOLA S., PULVIRENTI A., BOZZETTI F., MONTALTO F., Ammantuna M., Morahito A., Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Eng J Med, 1996, 334: 693-699.
VAN ROEY G., FEVERY J., VAN STEENBERGEN W. Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients. European J Gastroenterol Hepatol. 2000, 12: 61-6.
HENRION J., DE MAEGHT S., DELTENRE P., CHILAIN J.-M., MAISIN J.-M., SCHAPIRA M., HELLER F. Impact of hepatitis C virus infection on the aetiology of cirrhosis and hepatocarcinoma in the affiliated hospitals in Southern Belgium. Acta Gastroenterol Belg, 2002, 65: 80-82.
GRIECE A., POMPILI M., CAMINITI G., MIELE L., COVINO M., ALFEI B., RAPACCINI G. L., GASBARRINI G. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda. CLIP. BCLC staging systems in a single Italian centre. Gut, 2005, 54: 411-418.
OLTHOFF K., BROWN R., DELMONICO F., FREEMAN R., MCDIARMID S., MERION R., MILLIS J., ROBERTS J., SHARED A., WIESNER R., LUCEY M. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transplantation. 2004. vol. 10. N° 10. suppl 2: A6-A22.
